Do Multiple COVID-19 Vaccine Doses Affect Metabolism?

COVID-19 vaccines save lives, but concerns remain about long-term effects after multiple doses. New research from Murdoch University’s Australian National Phenome Centre reveals that multiple doses do not cause lasting metabolic or inflammatory changes.
Do Multiple COVID-19 Vaccine Doses Affect Metabolism?
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Explore the Research

SpringerLink
SpringerLink SpringerLink

Longitudinal study on immunologic, lipoproteomic, and inflammatory responses indicates the safety of sequential COVID-19 vaccination - Journal of Molecular Medicine

Abstract COVID-19 vaccines are crucial in reducing SARS-CoV-2 transmission and severe health outcomes. Despite widespread administration, their long-term systemic effects on human metabolism remain inadequately understood. This longitudinal study aims to evaluate IgG responses, 34 cytokines, 112 lipoproteins, and 21 low-molecular-weight metabolites in 33 individuals receiving two to four COVID-19 vaccine doses. Changes in metabolic profiles for the first 16 days post each dose of vaccine, and up to 480 days post-initial dose, were compared to baseline (before vaccination). Additionally, metabolic profiles of vaccinated participants were compared to a reference cohort of unvaccinated individuals without prior exposure to SARS-CoV-2 infection (controls) and SARS-CoV-2 cases. Positive IgG responses were observed in 78.8% (N = 26) of participants after the first dose, reaching 100% with subsequent doses. The most common side effects were localized pain at the injection site and “flu-like” symptoms, reported by > 50% of participants. Systemic side effects, e.g., sore lymph nodes, fatigue, and brain fog, were reported but showed no significant correlations to IgG responses. Transient temporal changes were observed for cytokine IP10 (CXCL10) and glutamic acid around the third vaccine dose. Compared to the reference cohort, 497 vaccinated samples (95.0%) had profiles similar to the controls, while the remaining 26 samples with prior infection exposures were similar to mild cases of SARS-CooV-2 infection. In conclusion, COVID-19 vaccination did not induce lasting changes in inflammatory and metabolic responses, nor did it induce changes similar to mild cases of SARS-CoV-2 infection. This supports the metabolic safety of the vaccine and contributes to increased vaccine confidence. Key messages Minimal changes in inflammatory/metabolic markers up to 480 days post-vaccination. Transient increase in IP10 (CXCL10) and glutamic acid around the third dose. Post-vaccination IgG response did not alter metabolic profiles like SARS-CoV-2 cases. Our findings provide insights into the safety of repeated COVID-19 vaccinations.

Study Overview:

This real-world longitudinal study, conducted in Western Australia, evaluated the metabolic and immunologic responses of 33 individuals who received up to four doses of either Pfizer-BioNTech (Comirnaty™) or Oxford-AstraZeneca (Vaxzevria™) vaccines. We tracked 34 cytokines, 112 lipoprotein markers, and 21 low-molecular-weight metabolites over a period extending up to 480 days after the first dose. Samples were collected immediately before and within two weeks after each vaccination to capture both short- and long-term biological responses.

Schematic of the study design: vaccination schedule in relation to the sample collection for each time-point, together with the type of assays performed and dropout rates. Created in https://BioRender.com

Key Findings:

1. Temporary Immune Activation

After vaccination, a short-lived increase was observed in inflammatory cytokines such as IP10 (CXCL10) and MIP-1β. Importantly, these cytokine levels quickly returned to baseline and remained well within normal healthy ranges between doses, indicating a controlled and transient immune response, distinct from the serious inflammatory patterns seen in COVID-19 infections.

2. Metabolic Stability

Metabolic profiling revealed minimal changes following vaccination.
To assess this, the vaccinated cohort's samples were compared to two reference groups:

  • Individuals with mild COVID-19 infections (PCR-positive, non-hospitalized), and
  • Healthy controls with samples collected before the pandemic.

Using mathematical modelling, we found that over 95% of the vaccinated individuals' blood profiles resembled healthy controls, not those with COVID-19 infection.

Approximately 5% of samples showed metabolic fingerprints more similar to mild COVID-19 cases.  Notably, half of these samples came from one individual later diagnosed with long COVID after overseas travel.

Created in https://BioRender.com

3. Small and Isolated Metabolic Shifts

Further analysis found a temporary increase in glutamic acid levels after the third vaccine dose. While intriguing, given glutamic acid’s role in immune regulation and cardiovascular health, the glutamine-to-glutamic acid ratio remained within normal ranges, suggesting no adverse functional impact.

Why It Matters:

This study provides real-world evidence that repeated COVID-19 vaccination does not induce harmful metabolic effects. It offers important reassurance for individuals seeking to stay current with recommended vaccine schedules without fearing long-term metabolic consequences.

Full Study:

The research is published in the Journal of Molecular Medicine:
Longitudinal study on immunologic, lipoproteomic, and inflammatory responses indicates the safety of sequential COVID-19 vaccination

Media:

Dr. Norman Swan discusses the findings on the ABC Health Report
Listen here

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Biomedical Research
Life Sciences > Health Sciences > Biomedical Research
Biological Chemistry
Physical Sciences > Chemistry > Biological Chemistry
Vaccines
Life Sciences > Biological Sciences > Immunology > Applied Immunology > Vaccines
Medical Biochemistry
Life Sciences > Health Sciences > Biomedical Research > Medical Biochemistry

Related Collections

With collections, you can get published faster and increase your visibility.

Ferroptosis: From Molecular Mechanisms to Clinical Applications

Ferroptosis is a unique form of regulated cell death driven by iron-dependent lipid peroxidation. Unlike apoptosis, necrosis, or autophagy, ferroptosis involves distinct metabolic and signaling pathways, making it a critical area of study with significant implications for understanding various diseases, including cancer, neurodegeneration, and ischemia-reperfusion injury. Over the past decade, the molecular mechanisms underlying ferroptosis have been extensively studied, revealing potential therapeutic targets that could lead to innovative treatments for a wide range of diseases. Given the substantial growth in research focused on ferroptosis, it is timely to bring together leading experts in the field to present their latest findings and perspectives. This special issue aims to provide a comprehensive overview of the current state of ferroptosis research, spanning from fundamental molecular mechanisms to translational research and potential clinical applications.

The special issue will cover a broad spectrum of topics related to ferroptosis, including but not limited to:

A. Molecular Mechanisms of Ferroptosis: including (1) Role of iron metabolism in ferroptosis. (2) Lipid peroxidation and antioxidant defense mechanisms. (3) Genetic and epigenetic regulation of ferroptosis. (4) Signaling pathways involved in ferroptosis initiation and execution.

B. Ferroptosis in Disease: including (1) Ferroptosis in cancer: potential for therapeutic targeting; (2) Neurodegenerative diseases and ferroptosis.(3) Ferroptosis in cardiovascular diseases, including ischemia-reperfusion injury. (4)The role of ferroptosis in inflammation and immune response.

C. Therapeutic Strategies: (1) Small molecules and natural compounds targeting ferroptosis.(2) Ferroptosis inhibitors and their potential clinical applications. (3) Biomarker development for ferroptosis-related diseases. (4) Preclinical and clinical studies exploring ferroptosis-based therapies.

Keywords: Ferroptosis; Iron metabolism; Lipid peroxidation; Antioxidant defense; Neurodegenerative diseases; Cardiovascular diseases; Therapeutic targeting; Biomarkers; Inflammation; Cell death; Cancer therapy.

Publishing Model: Hybrid

Deadline: Dec 31, 2025